Ethicon Company History Timeline

1915

The Edinburgh facility was opened in 1915 to manufacture and sell catgut, silk and nylon sutures.

1947

Johnson & Johnson bought G.F. Merson Limited in 1947.

1949

Ethicon, Inc. is a subsidiary of Johnson & Johnson, incorporated in 1949 according to Wikipedia, to expand the product line.

Under Johnson & Johnson’s control, G.F. Merson Limited became Ethicon Suture Laboratories in 1949.

1958

Merson stayed involved in the company until his death in 1958.

1969

By 1969 PROLENE® Propylene Suture became the “gold standard” for cardiac bypass surgery and eventually would become the material eventually used to make hernia mesh then transvaginal mesh.

1970

In 1970 Ethicon LTD., of Edinburgh, Scotland, produced this book called Ethicon infirmary about the origin of the name "catgut", another name for suture material.

1974

Coated VICRYL® was introduced in 1974 for use in general surgery.

1992

By 1992, Ethicon was restructured and Ethicon Endo-Surgery became a separate company.

2008

In 2008, the company sold its wound management business to One Equity Partners.

2009

2009 Mentor – breast implant maker

2011

Covering mesh issues from a patient’s perspective since 2011.

2012

But, in 2012, the company stopped selling four of its Gynecare mesh products.

2013

By May 2013, the companies consolidated again and rebranded to form Ethicon Endo-Surgery to merge its surgical sutures and wound closure devices with medical devices and surgical instruments specializing in minimally-invasive surgery.

2016

January 2016 Johnson & Johnson agreed to pay $120 million to settle thousands of mesh lawsuits.

February 2016 A jury awarded $4.4 million to a Florida resident injured by Mentor’s ObTape sling for urinary incontinence.

Ethicon pulled its popular Physiomesh Flexible Composite Hernia Mesh from the market worldwide in 2016.

2017

Mesh Medical Device News Desk, January 17, 2017 ~ Long before there was transvaginal mesh made by Johnson & Johnson, the company made suture material, known as "catgut" because it was manufactured from the submucosal layer of the small intestines of a sheep.

January 24, 2017 at 8:30 am EST J&J will discuss its 4Q earnings in a call and Webcast. http://www.investor.jnj.com/investor-relations.cfm

April 2017 A Philadelphia jury awarded $20 million to a patient who received Ethicon’s TVT-Secur and suffered transvaginal mesh complications.

September 2017 A Philadelphia jury awarded $57.1 million to a patient injured by two of Ethicon’s pelvic mesh implants.

2018

March 2018 An Indiana jury awarded $35 million to a patient injured by Ethicon’s Prolift mesh implant.

2019

April 2019 A Philadelphia jury awarded $120 million to a woman who received Ethicon’s TVT-O mesh implant.

May 2019 A Pennsylvania jury awarded $80 million to a woman who had a Prolift mesh implant.

Perriello, B. (2019, May 9). J&J’s Ethicon buys Takeda’s TachoSil fibrin patch for $400m.

Ethicon agreed to pay $117 million to 41 states and the District of Columbia to settle claims for deceptive marketing of its pelvic mesh products in October 2019.

Hale, C. (2019, October 18). J&J, Ethicon to pay $117M to settle states' transvaginal mesh marketing lawsuits.

2019 TachoSil — Fibrin patch business from Takeda Pharmaceutical

2020

Johnson & Johnson’s surgery franchise made $8.2 billion in sales in 2020, according to Johnson and Johnson’s 2020 annual report.

Cases continue to be filed, but they remain outside the MDL. Ethicon still faces 14,900 pelvic mesh lawsuits, according to the 2020 annual report.

2021

As of March 15, 2021, Ethicon faced 3,365 Physiomesh lawsuits in multidistrict litigation in Georgia.

© 2021 Drugwatch.com Privacy Policy / Do Not Sell My Info

Founded
1915
Company Founded
Headquarters
Cincinnati, OH
Company Headquarter
Founders
George Merson
Company Founders

Ethicon Jobs Nearby

Ethicon Jobs

Ethicon Similar Companies

Find Jobs from Similar Companies
Personalize your job search. Where would you like to work?
0 selections

Ethicon Similar Companies Jobs